Exercise Clinical Trial
Official title:
Body Composition and Lipid Metabolism at Rest and During Exercise: A Cross-Sectional Analysis.
NCT number | NCT03029364 |
Other study ID # | 17/SW/0269 |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | January 8, 2018 |
Est. completion date | May 11, 2024 |
Verified date | May 2024 |
Source | University of Bath |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
The ability to upregulate fat oxidation at appropriate times such as during fasting, low to moderate intensity exercise and after a high fat meal, is popularly advocated. This is presumably due to the perception that a high capacity to utilise fat may improve (ultra) endurance performance and help in the regulation of body fat and metabolic diseases. In accordance, impaired fat use at rest has been associated with obesity and insulin resistance (Kelley et al., 1999). However, there is inconclusive and / or a lack of systematic evidence, especially in a large diverse range of adults, exploring: 1) Whether whole body fat use during exercise is altered in individuals with overweight or obesity compared to lean individuals 3) The intra-individual variability in whole-body fat use at rest and during exercise 4) Physiological, metabolic, lifestyle and genetic characteristics that are associated with whole-body fat use at rest and during exercise Therefore, the objectives of this study are three-fold: 1. To explore whether whole body fat use is associated with body composition 2. To explore associations between whole-body fat use and physiological, metabolic, lifestyle and genetic variables 3. To assess the intra-individual variability of whole-body fat use. This study is an observational, exploratory cross-sectional study. A wide range of 'healthy' and 'at-risk of metabolic disease' adults will be recruited. Participants will be asked to visit a laboratory at the University of Bath four times. Visit 1 is a screening and study familiarisation visit. Visits 2 and 3 are to be completed within 7-14 days and involve lifestyle monitoring (dietary and physical activity), a one-off urine and blood sample, assessment of fuel use at rest and during exercise (the latter through an incremental graded cycling exercise test to exhaustion). Visit 4 is to assess body composition via a dual-energy x-ray absorptiometry (DEXA) scan in addition to an optional skeletal muscle and / or fat tissue biopsy.
Status | Completed |
Enrollment | 114 |
Est. completion date | May 11, 2024 |
Est. primary completion date | May 28, 2019 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 65 Years |
Eligibility | Inclusion Criteria: - be between 18 - 65 years of age - male or female - body mass index between 18.9 - 35 kg/m2 - be able and willing to give informed oral and written consent - complete and meet the defined criteria of pre-study questionnaires and screens Exclusion Criteria: - Currently have or have a previous history of metabolic, cardio-pulmonary or musculoskeletal disease - BMI below 18.9 or above 35 kg/m2 - Have plans to change lifestyle (diet and/or physical activity) during the study period ( 7 - 21 days) - Unwillingness or unable to sufficiently meet study demands |
Country | Name | City | State |
---|---|---|---|
United Kingdom | Department for Health, University of Bath | Bath |
Lead Sponsor | Collaborator |
---|---|
University of Bath |
United Kingdom,
ANDRES R, CADER G, ZIERLER KL. The quantitatively minor role of carbohydrate in oxidative metabolism by skeletal muscle in intact man in the basal state; measurements of oxygen and glucose uptake and carbon dioxide and lactate production in the forearm. J Clin Invest. 1956 Jun;35(6):671-82. doi: 10.1172/JCI103324. No abstract available. — View Citation
Ara I, Larsen S, Stallknecht B, Guerra B, Morales-Alamo D, Andersen JL, Ponce-Gonzalez JG, Guadalupe-Grau A, Galbo H, Calbet JA, Helge JW. Normal mitochondrial function and increased fat oxidation capacity in leg and arm muscles in obese humans. Int J Obes (Lond). 2011 Jan;35(1):99-108. doi: 10.1038/ijo.2010.123. Epub 2010 Jun 15. — View Citation
Barwell ND, Malkova D, Leggate M, Gill JM. Individual responsiveness to exercise-induced fat loss is associated with change in resting substrate utilization. Metabolism. 2009 Sep;58(9):1320-8. doi: 10.1016/j.metabol.2009.04.016. Epub 2009 Jun 18. — View Citation
Blaize AN, Potteiger JA, Claytor RP, Noe DA. Body fat has no effect on the maximal fat oxidation rate in young, normal, and overweight women. J Strength Cond Res. 2014 Aug;28(8):2121-6. doi: 10.1519/JSC.0000000000000512. — View Citation
Croci I, Hickman IJ, Wood RE, Borrani F, Macdonald GA, Byrne NM. Fat oxidation over a range of exercise intensities: fitness versus fatness. Appl Physiol Nutr Metab. 2014 Dec;39(12):1352-9. doi: 10.1139/apnm-2014-0144. Epub 2014 Aug 1. — View Citation
Dandanell S, Husted K, Amdisen S, Vigelso A, Dela F, Larsen S, Helge JW. Influence of maximal fat oxidation on long-term weight loss maintenance in humans. J Appl Physiol (1985). 2017 Jul 1;123(1):267-274. doi: 10.1152/japplphysiol.00270.2017. Epub 2017 May 25. — View Citation
Ellis AC, Hyatt TC, Hunter GR, Gower BA. Respiratory quotient predicts fat mass gain in premenopausal women. Obesity (Silver Spring). 2010 Dec;18(12):2255-9. doi: 10.1038/oby.2010.96. Epub 2010 May 6. — View Citation
Goodpaster BH, Sparks LM. Metabolic Flexibility in Health and Disease. Cell Metab. 2017 May 2;25(5):1027-1036. doi: 10.1016/j.cmet.2017.04.015. — View Citation
Goodpaster BH, Wolfe RR, Kelley DE. Effects of obesity on substrate utilization during exercise. Obes Res. 2002 Jul;10(7):575-84. doi: 10.1038/oby.2002.78. — View Citation
Hopkins M, Blundell JE, King NA. Individual variability in compensatory eating following acute exercise in overweight and obese women. Br J Sports Med. 2014 Oct;48(20):1472-6. doi: 10.1136/bjsports-2012-091721. Epub 2013 May 10. — View Citation
Horowitz JF, Klein S. Oxidation of nonplasma fatty acids during exercise is increased in women with abdominal obesity. J Appl Physiol (1985). 2000 Dec;89(6):2276-82. doi: 10.1152/jappl.2000.89.6.2276. — View Citation
Kelley DE, Goodpaster B, Wing RR, Simoneau JA. Skeletal muscle fatty acid metabolism in association with insulin resistance, obesity, and weight loss. Am J Physiol. 1999 Dec;277(6):E1130-41. doi: 10.1152/ajpendo.1999.277.6.E1130. — View Citation
Kelley DE, Mandarino LJ. Fuel selection in human skeletal muscle in insulin resistance: a reexamination. Diabetes. 2000 May;49(5):677-83. doi: 10.2337/diabetes.49.5.677. — View Citation
Kelley DE, Mandarino LJ. Hyperglycemia normalizes insulin-stimulated skeletal muscle glucose oxidation and storage in noninsulin-dependent diabetes mellitus. J Clin Invest. 1990 Dec;86(6):1999-2007. doi: 10.1172/JCI114935. — View Citation
Lanzi S, Codecasa F, Cornacchia M, Maestrini S, Salvadori A, Brunani A, Malatesta D. Fat oxidation, hormonal and plasma metabolite kinetics during a submaximal incremental test in lean and obese adults. PLoS One. 2014 Feb 11;9(2):e88707. doi: 10.1371/journal.pone.0088707. eCollection 2014. — View Citation
Perez-Martin A, Dumortier M, Raynaud E, Brun JF, Fedou C, Bringer J, Mercier J. Balance of substrate oxidation during submaximal exercise in lean and obese people. Diabetes Metab. 2001 Sep;27(4 Pt 1):466-74. — View Citation
Romijn JA, Coyle EF, Sidossis LS, Gastaldelli A, Horowitz JF, Endert E, Wolfe RR. Regulation of endogenous fat and carbohydrate metabolism in relation to exercise intensity and duration. Am J Physiol. 1993 Sep;265(3 Pt 1):E380-91. doi: 10.1152/ajpendo.1993.265.3.E380. — View Citation
Rynders CA, Blanc S, DeJong N, Bessesen DH, Bergouignan A. Sedentary behaviour is a key determinant of metabolic inflexibility. J Physiol. 2018 Apr 15;596(8):1319-1330. doi: 10.1113/JP273282. Epub 2017 Jul 4. — View Citation
Seidell JC, Muller DC, Sorkin JD, Andres R. Fasting respiratory exchange ratio and resting metabolic rate as predictors of weight gain: the Baltimore Longitudinal Study on Aging. Int J Obes Relat Metab Disord. 1992 Sep;16(9):667-74. — View Citation
Shook RP, Hand GA, Paluch AE, Wang X, Moran R, Hebert JR, Jakicic JM, Blair SN. High respiratory quotient is associated with increases in body weight and fat mass in young adults. Eur J Clin Nutr. 2016 Oct;70(10):1197-1202. doi: 10.1038/ejcn.2015.198. Epub 2015 Nov 25. — View Citation
van Loon LJ, Greenhaff PL, Constantin-Teodosiu D, Saris WH, Wagenmakers AJ. The effects of increasing exercise intensity on muscle fuel utilisation in humans. J Physiol. 2001 Oct 1;536(Pt 1):295-304. doi: 10.1111/j.1469-7793.2001.00295.x. — View Citation
* Note: There are 21 references in all — Click here to view all references
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Maximal rate of whole-body fat oxidation (mg/kg FFM/min) | Fat free mass (FFM). Assessed during the incremental stage maximal cardio-respiratory fitness test | 7 - 14 days | |
Secondary | Maximal rate of whole-body fat oxidation (g/min) | Non-adjusted rate. Assessed during the incremental stage maximal cardio-respiratory fitness test | 7-14 days | |
Secondary | FATmax (% of maximum oxygen consumption) | The exercise intensity that maximal rate of whole-body fat oxidation occurs at. Expressed as % of VO2peak). Assessed during the incremental stage maximal cardio-respiratory fitness test. | 7 - 14 days | |
Secondary | FATmax (% of Watt max) | The exercise intensity that maximal rate of whole-body fat oxidation occurs at. Expressed as % of Watt max). Assessed during the incremental stage maximal cardio-respiratory fitness test. | 7 - 14 days | |
Secondary | FATmax (% of Heart Rate max) | The exercise intensity that maximal rate of whole-body fat oxidation occurs at. expressed either as % of heart rate max). Assessed during the incremental stage maximal cardio-respiratory fitness test | 7 - 14 days | |
Secondary | Whole-body substrate oxidation rates (Carbohydrates and Lipid) during exercise | Assessed during the incremental stage maximal cardio-respiratory fitness test via indirect calorimetry of expired gas samples. | 7 - 14 days | |
Secondary | Whole-body substrate oxidation rates (Carbohydrates and Lipid) at rest | Assessed at rest through the participant lying in a semi-supine position via indirect calorimetry of expired gas samples. | 7 - 14 days | |
Secondary | Resting metabolic rate | Assessed at rest through the participant lying in a semi-supine position via indirect calorimetry of expired gas samples. | 7 - 14 days | |
Secondary | Cardiorespiratory fitness (VO2peak) | Assessed during the incremental stage maximal cardio-respiratory fitness test | 7 - 14 days | |
Secondary | Habitual Energy Intake | Participants will be asked to complete a self-weighed food and drink diary before each main trial day (Visit 2 and 3) so that average daily calorie and macronutrient intake can be calculated. The procedure will be explained by the CI. This diet monitoring period must include 3 week-days, at least one 1 weekend day and the immediate 48-hrs prior to the beginning of each main trial (Visit 2 and 3). Additionally, the prior 48-hrs before Visit 2 will be replicated before Visit 3. | 7 - 21 days | |
Secondary | Habitual Energy Expenditure / Physical Activity | Physical activity will be measured by accelerometry and heart-rate monitoring for 7 days before each main trial day (Visit 2 and 3). This procedure will be explained by the CI. ntake can be calculated. The participants physical activity levels for the immediate 48-hrs prior to the beginning of each main trial (Visit 2 and 3) will be asked to be replicated as closely as possible. | 7 - 21 days | |
Secondary | Menstrual Cycle (females only) | Assessed through a self-reported menstrual cycle questionnaire | 7 - 21 days | |
Secondary | Self-reported Physical Activity level | Assessed by the International Physical Activity Questionnaire (long form) | 7-21 days | |
Secondary | Fasting glucose concentration | Assessed via plasma sample extracted from the blood sample | 7-21 days | |
Secondary | Fasting lipid profiles (triglycerides / cholesterol) | Assessed via serum sample extracted from the blood sample | 7-21 days | |
Secondary | Fasting Adipose tissue derived hormone concentrations (leptin, adiponectin) | Assessed via plasma sample extracted from the blood sample | 7-21 days | |
Secondary | Fasting catecholamine concentrations (epinephrine and norepinephrine) | Assessed via plasma sample extracted from the blood sample | 7-21 days | |
Secondary | Fasting sex hormone concentrations (17 beta-estradiol, testosterone, progesterone) | Assessed via serum sample extracted from the blood sample | 7-21 days | |
Secondary | Fasting pancreatic derived hormone concentrations (insulin and glucagon) | Assessed via plasma sample extracted from the blood sample | 7-21 days | |
Secondary | Hydration Status (urine specific gravity) | Assessed via analysis of urine sample with a refractometer | 7-21 days | |
Secondary | Age | Assessed via a participant questionnaire | 7-21 days | |
Secondary | Sex | Assessed via a participant questionnaire | 7-21 days | |
Secondary | Ethnicity | Assessed via a participant questionnaire | 7-21 days | |
Secondary | Smoking Status | Assessed via a participant questionnaire | 7-21 days | |
Secondary | Medication / supplement use | Assessed via a participant questionnaire | 7-21 days | |
Secondary | Dietary pattern / requirements (e.g. vegetarian, vegan, Celiac disease) | Assessed via a participant questionnaire | 7-21 days | |
Secondary | Body Mass (kg) | Assessed via body weighing scales | 7-21 days | |
Secondary | Body Mass Index (kg/m2) | Assessed by dividing body weight in kg by height in metres squared. | 7-21 days | |
Secondary | Waist circumference (cm) | Assessed via use of an anthropometric tape measure | 7-21 days | |
Secondary | Hip Circumference (cm) | Assessed via use of an anthropometric tape measure | 7-21 days | |
Secondary | Body fat percentage | Assessed via a dual energy xray absorptiometry scan at Visit 4. | 1 day | |
Secondary | Body fat localisation | Assessed via a dual energy xray absorptiometry scan at Visit 4. | 1 day | |
Secondary | Lean body mass | Assessed via a dual energy xray absorptiometry scan at Visit 4. | 1 day | |
Secondary | Body fat percentage | Bioelectrical Impedance Analysis from the body weighing scales | 7-21 days | |
Secondary | Genotyping analysis | Genotyping analysis will be assessed through the extraction of the buffy coat layer from the blood sample | 7 - 21 days | |
Secondary | Skeletal Muscle sample (Optional) | The optional muscle sample will be obtained from the quadriceps muscle using the Bergstrom technique on Visit 4. | 1 day | |
Secondary | Adipose Tissue (Fat) sample (Optional) | The optional fat sample will be obtained from the subcutaneous abdominal region (5 cm laterally of the umbilicus) via the 'lipoaspiration' technique on Visit 4. | 1 day | |
Secondary | Fat mass index (body fat in kg/m2) | Assessed by dividing body fat in kg by height in metres squared. | 7 - 21 days |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05156424 -
A Comparison of Aerobic and Resistance Exercise to Counteract Treatment Side Effects in Men With Prostate Cancer
|
Phase 1/Phase 2 | |
Completed |
NCT05108181 -
Muscle Typology and Strength Training Adaptations
|
N/A | |
Recruiting |
NCT05052918 -
The Effect of Exercise and Metformin on Carotid Intima-media Thickness in Patients With Prediabetes
|
N/A | |
Completed |
NCT04508270 -
Significance of Early Mobilization After VATS-L
|
||
Recruiting |
NCT04994340 -
Physical Activity Observatory of Castilla-La Mancha
|
||
Completed |
NCT04815980 -
Impact of Pilates on Running Mechanics
|
N/A | |
Completed |
NCT05189795 -
The Construction of Physical ACtivity Enhancement Scheme (PACES) in Hemodialysis Patients
|
||
Completed |
NCT03683758 -
Effects of the FIFA11+ Warm-up Program on Speed, Agility, and Vertical Jump Performance in Adult Female Amateur Soccer Players
|
N/A | |
Completed |
NCT05538520 -
Effects of Pilates Stretching on Flexibility, Strength, Power and Muscular Endurance
|
N/A | |
Completed |
NCT06315036 -
Effects of Developmental Gymnastics on Preschoolers' Motor Skills
|
N/A | |
Completed |
NCT03171064 -
Exercise as a Supportive Measure for Patients Undergoing Checkpoint-inhibitor Treatment
|
Phase 2 | |
Recruiting |
NCT05496751 -
Response Variability to Exercise
|
N/A | |
Not yet recruiting |
NCT05029804 -
Effect of Walking Exercise Training on Adherence to Disease Management and Metabolic Control in Diabetes
|
N/A | |
Completed |
NCT04207359 -
Effects of Creatine Supplementation in Breast Cancer Survivors
|
N/A | |
Completed |
NCT04099654 -
The Effect of Core Stabilization Exercise Program in Obese Subjects Awaiting Bariatric Surgery
|
N/A | |
Completed |
NCT03832205 -
Validation of Respiratory Rate and Heart Rate Measurements by Capaciflectors Placed in Four Locations on the Chest
|
||
Completed |
NCT03477188 -
The Effects of Somatosensory and Vestibular Rehabilitation Additional Conventional Therapy on Balance in Patients With Acute Stroke.
|
N/A | |
Completed |
NCT03297567 -
Physical Therapy Guidelines For Hospitalized Elderly
|
N/A | |
Recruiting |
NCT05956327 -
Insight Into Hippocampal Neuroplasticity in Schizophrenia by Investigating Molecular Pathways During Physical Training
|
N/A | |
Recruiting |
NCT06018311 -
Exercising Together for Hispanic Prostate Cancer Survivor-Caregiver Dyads
|
N/A |